Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
The statistic displays the quarterly share of Celltrion's Remsima in the European market from the first quarter of 2015 to the second quarter of 2018. As of Q2 2018, the Remsima products from South Korean biopharmaceutical company Celltrion took up around 54 percent within the European market, increased from 53 percent in the previous quarter.
